explore -WSS

explore

author：focus 2025-10-04 07:30:24 - browse：1

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： Adam's Biotech Scorecard: Do Sarepta's exon

WSS

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Akili, maker of video game for ADHD, to be acquired for 34 million

HPV cancer vaccine study demonstrates efficacy

Insmed lung disease drug hits target in key Phase 3 trial

10 million people disenrolled from Medicaid over past six months

hotspot

explore

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

The Sacklers, horror, and ‘The Fall of the House of Usher’

Heart attack and stroke risk calculators need revising

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Walensky prepares to leave CDC — and Congress — behind

Lab trade group sues FDA to halt regulation of lab

The high cost of giving birth even with insurance

Removing probiotics from the NICU could threaten preemies' health

Psychedelics group wrestles with new pharma identity

Antibiotic resistance nearly killed me, so I'm raising awareness of it

knowledge

The Sacklers, horror, and ‘The Fall of the House of Usher’

Free speech concerns arise in wake of journal editor Eisen's firing

iTeos Therapeutics debuts first data on TIGIT

Diversify hospital leadership teams to protect BIPOC patient health

Abortion clinic in Cancun will cater to Americans

Medicare solvency divides Republicans at the presidential debate

focus

knowledge

hotspot

explore